| 主な業績 |
論文
- Okamoto K, Tanaka F, et al. Significance of Serum Cholinesterase as a Prognostic Marker in Patients with Non-dialysis-dependent Chronic Kidney Disease. Intern Med. 2025; 64: 3188-96.
- Kikuchi Y, Tanaka F, et al. Utility of urinary albumin excretion as an index for stratifying the residual cardiovascular risk in patients undergoing antihypertensive agents treatment. J Hypertens. 2021; 39: 2431-38.
- Takahashi T, Tanaka F, et al. Five-year blood pressure trajectories of survivors of the tsunami following the Great East Japan Earthquake in Iwate. Hypertens Res. 2021; 44: 581-90.
- Tanaka F, Komi R, et al. Additional prognostic value of electrocardiographic left ventricular hypertrophy in traditional cardiovascular risk assessments in chronic kidney disease. J Hypertens. 2020; 38: 1149-57.
- Tanaka K, Tanaka F, et al. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population. Am J Hypertens. 2018;31: 895-901.
- Komi R, Tanaka F, et al. Burden of high blood pressure as a contributing factor to stroke in the Japanese community-based diabetic population. Hypertens Res. 2018;41: 531-38.
- Tanaka F, Komi R, et al. Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals. J Hypertens. 2016; 34: 506-12.
著書(和文)
- 田中文隆. 痛風?高尿酸血症治療薬 フェブリク.なんで使うの?そのくすり.東京:南江堂; 2023: p.133-6.
- 田中文隆.血清尿酸値>7.0mg/dL 高尿酸血症と痛風.本日の内科外来.東京:南江堂;2023: p.10-14.
- 田中文隆,旭浩一.無症候性血尿?蛋白尿(家族性良性血尿).腎疾患?透析最新の治療2020-2022.東京:南江堂;2020:p.120-22.
総説(和文)
- 田中文隆. 高齢者CKDに対する栄養管理の課題. 細胞The CELL Vol.57 No12, 871-75, 2025.
|